Efficacy of axitinib in patients with metastatic renal cell carcinoma refractory to nivolumab therapy-Reference-Cited by-同舟云学术

Efficacy of axitinib in patients with metastatic renal cell carcinoma refractory to nivolumab therapy

Published:2019-03-29 Issue:6 Volume:49 Page:576-580
ISSN:1465-3621
Container-title:Japanese Journal of Clinical Oncology
language:en
Short-container-title:

Author:

Yoshida Kazuhiko¹,Takagi Toshio¹,Kondo Tsunenori²,Kobayashi Hirohito¹,Iizuka Junpei¹,Fukuda Hironori¹,Ishihara Hiroki¹^ORCID,Okumi Masayoshi¹^ORCID,Ishida Hideki¹,Tanabe Kazunari¹

Affiliation:

1. Department of Urology, Tokyo Women’s University Hospital, Tokyo, Japan

2. Department of Urology, Tokyo Women’s Medical University Medical Center East, Tokyo, Japan

Publisher

Oxford University Press (OUP)

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology,General Medicine

Link

http://academic.oup.com/jjco/article-pdf/49/6/576/28757544/hyz040.pdf

Reference21 articles.

1. Kidney Cancer, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology;Motzer;J Natl Compr Canc Netw,2017

2. Updated European Association of Urology Guidelines Recommendations for the treatment of first-line metastatic clear cell renal cancer;Powles;Eur Urol,2017

3. Nivolumab versus everolimus in advanced renal-cell carcinoma;Motzer;N Engl J Med,2015

4. Antiangiogenic therapy combined with immune checkpoint blockade in renal cancer;Kuusk;Angiogenesis,2017

5. Increased response rates to salvage chemotherapy administered after PD-1/PD-L1 inhibitors in patients with non-small cell lung cancer;Park;J Thorac Oncol,2018

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Identifying potential risk genes for clear cell renal cell carcinoma with deep reinforcement learning;2024-06-23

2. Indazole as a privileged scaffold in drug discovery;Privileged Scaffolds in Drug Discovery;2023

3. Renal Cell Carcinoma in End-Stage Renal Disease: A Review and Update;Biomedicines;2022-03-11

4. Synthesis and Antitumor Activity of Novel 5- and 6-Substituted Indazole Derivatives;Chinese Journal of Organic Chemistry;2022

5. Indazole as a Privileged Scaffold: The Derivatives and their Therapeutic Applications;Anti-Cancer Agents in Medicinal Chemistry;2021-05